Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Collège royal > Troubles anxieux > Flashcards

Troubles anxieux Flashcards

1
Q

what is the lifetime prevalence of anxiety disorders

A

31% estimated (higher than mood or SUDs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

about what % of those with anxiety and related disorders are untreated

A

estimated 40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the increased risk of suicide associated with anxiety disorders

A

1.7-2.5x risk of suicide attempts

*unclear if moderated by gender

*increased risk of suicide attempt in PTSD, GAD and panic disoder even in absence of comorbid mood disorder (though presence of comorbid mood disorder greatly increases risk)

*must explicitly evaluate suicide risk in anxiety patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

family history of anxiety or mood disorders offers what prognostic information for those with anxiety disorders

A

more recurrent course

greater impairment

greater service use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

list common risk factors in patients with anxiety and related disorders

A

family history of anxiety

personal history of anxiety or mood disorder

childhood stressful life events or trauma

being female

chronic medical illness

behavioural inhibition

*loneliness, low education, adverse parenting, chronic somatic illness may increase lifetime risk of diagnosis of anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what % of those with anxiety and related disorders also have another anxiety disorder

A

50%

often substance use or mood disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what medical illnesses are more common in those with anxiety and related disorders compared to those without anxiety and related disorders

A

HTN

other CV conditons

GI disease

arthritis

thyroid disease

respiratory disease

migraine headaches

allergic conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what should ALL patients with anxiety and related disorders receive in terms of treatment

A

education about their disorder

efficacy and tolerability of treatment choices

aggravating factors

signs of relapse

information in self help materials ie books

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are some of the factors that might determine whether to pursue pharmacological or psychological treatment for anxiety and related disorders

A

patient preference and motivation

ability of patient to engage in the treatment

severity of illness

clinician skills and experience

availability of psychological treatments

patients prior response to treatment

presence of comorbid medical or psychiatric disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how does efficacy differ between pharmacotherapy and psychological treatment for anxiety and related disorders

A

about equivalent efficacy for most anxiety and related disorders

results of combo therapy vary between disorders and results have been comflicting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the most common SEs with SSRIs, SNRIs

A

headache

sexual dysfunction

insomnia

GI upset

irritability

tremor

drowsiness

increased anxiety

weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which SEs of SSRIs, SNRIs may persist throughout treatment

A

weight gain and sexual dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the most common SEs with benzos

A

sedation

fatigue

ataxia

slurred speech

memory impairment

weakness

*associated with withdrawal reactions, rebound and dependence (risk greater with short and medium rather than long acting formulations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

can benzos cause cognitive impairment after discontinuation

A

yes–> has been reported persisting beyond cessation of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

side effects of buspirone

A

dizziness

drowsiness

nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how long should pharmacotherapy continue for most patients with anxiety and related disorders

A

at least 12-24 months

(longer term therapy associated with continued symptomatic improvement and the prevention of relapse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is a scale to measure the impact of an illness on functioning

A

Sheehan disability scale

or

SF-36

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the lifestime estimated prevalence of panic attacks

A

28.3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what % of the general public will have a panic attack without ever developing any identifiable psychopathology

A

about 8-10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

rates of panic disorder/agoraphobia are higher in which populations

A

women

middle aged

widowed-divorced

low income

**NO difference in urban vs rural setting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

which was more effective for panic disorder, CBT that included interoceptive exposure or relaxation therapy

A

CBT that included interoceptive exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

name two factors that improved the effectiveness of psychological treatments for panic disorder

A

inclusion of homework

follow up program

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how do minimal intervention formats I.e self help books, internet based CBT, compare in efficacy compared to other psychological treatments for panic disorder

A

more effective than wait list or relaxation controls

as effective as face to face CBT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

list predictors of decreased response to CBT for panic disorder

A

severity of panic disorder

strength of blood/injury fears

earlier age of onset of initial symptoms

comorbid social anxieties

degree of agoraphobic avoidance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
in panic disorder, is combo CBT + med therapy superior?
seems to be better than either CBT or meds alone during acute treatment phase and while meds were continued
26
is there benefit to CBT + benzos for treatment of panic disorder
does not seem to be (compared with psychotherapy or meds alone) *followup suggests combo might be WORSE than behaviour therapy alone
27
what has been shown to be helpful in facilitating benzo discontinuation in those with panic disorder
CBT
28
how long were benefits of CBT maintained for those with panic disorder
up to 3 years (one study shows 62% remained in remission after 10 years(
29
list first line meds for treatment of panic disorder
Call Every Familiar Fun Person Said Veronica *SSRIs/SNRIs Citalopram Escitalopram Fluoxetine Fluvoxamine Paroxetine Sertraline Venlafaxine XR
30
list second line meds for treatment of panic disorder
All Cats Can Dance In Lazy Morning Rounds *lots of benzos in this list Alprazolam Clomipramine Clonazepam Diazepam Imipramine Lorazepam Mirtazapine Reboxetine
31
what medications are NOT recommended in panic disorder
buspirone propanolol tiagabine trazodone
32
are there any first line adjunctive therapies for panic disorder
no
33
list two second line adjunctive therapies for panic disorder
alprazolam, clonazepam
34
how does efficacy compare between TCAs and SSRIs in the treatment of panic disorder
similar efficacy but TCAs tend to be not as well tolerated and have higher discontinuation rates
35
in which patients with panic disorder might you consider moclobemide and why
treatment resistant patients who are severely ill as while results for efficacy mixed for panic disorder, shows significant efficacy in severely ill patients
36
how effective is risperidone at treating panic disorder
RCT showing risperidone having similar efficacy as paroxetine to treat panic disorder
37
list the 3 AAPs with evidence (open label) for treating panic disorder
olanzapine risperidone quetiapine
38
why might you consider using alprazolam or clonazepam short term at initiation of SSRI therapy for panic disorder
can lead to a more rapid response use for less than 8 weeks including taper of the benzo
39
is there evidence for neurostimulation treatment for panic disorder
open label/level 3/4 evidence 1. REAC (radioeelctric asymmetric conveyor)--> efficacy for panic sx and agoraphobia 2. rTMS in patients with comorbid MDD but results mixed
40
what are some alternative therapies for panic disorder
1. capnometry assisted respiratory training --> was as effective as cognitive training in reducing symptom severity and panic related cognitions and improving perceived control (results mixed) 2. exercise groups seemed to do better than relaxation groups but not significant --> acute aerobic exercise found to reduce anxiety as well as panic attack frequency and intensity compared to quiet rest condition
41
who is considered to have treatment refractory panic disorder
those who do not respond to first or second line agents *in this case, reassess dx and consider comorbid medical and psych conditions that may be affecting tx then can consider third line agents and adjunctive therapies, as well as biological and alternative treatments
42
what is the treatment of choice for specific phobias
psychosocial interventions--> particularly EXPOSURE BASED treatments in vivo exposures better at posttreatment but not at follow up (compared to other types of effective exposures like virtual reality or imaginal)
43
list factors that have shown to make exposure based therapy for specific phobias more effective
sessions are grouped closely together exposure is prolonged exposure is real (vs imagined) exposure is provided in multiple settings there is some degree of therapist involvement *one session can be effective but greater number of sessions predicted more favorable outcomes
44
for specific phobias treatment, is flooding or gradual exposure more effective
no evidence either way but progressive exposures are more tolerable to patients generally
45
are psychological treatment outcomes for specific phobias moderated by the type of specific phobia?
no--> but studies have suggested that certain types may respond more favorably to specific types of treatment
46
what should be combined with exposure therapy for those with blood/injection/needle phobia
muscle tension exercises (applied tension) designed to prevent fainting use of stress reducing medical devices like decorated butterfly needles and syringes (for both adults and kids)
47
what type of psychosocial intervention is recommended for fear of flying
group CBT computer generated VR exposure (bibliotherapy less effective)
48
list some specific phobias for which virtual reality exposures have evidence of efficacy
fear of flying fear of heights claustrophobia arachnophobia
49
what compound has been speculated to improve extinction of fear in patients with specific phobias undergoing behavioural exposure therapy
d-cycloserine --> RCT combining with VRE for acrophobia showed significantly larger reductions in symptoms compared to VRE alone (but other results mixed) adjunctive cortisol --> ?cortisol may facilitate the extinction of phobic fear at follow up
50
what is d-cycloserine
a partial agonist at the NMDA receptor speculated to improve extinction of fear in patient with specific phobias undergoing behavioural exposure therapy
51
what is yohimbine
yohimbine hydrochloride = noradrenaline agonist ?facilitate fear extinction as enhanced emotional memory may be stimulated through elevated noradrenaline levels not good data from RCTs
52
is there a large role for pharmacotherapy in the treatment of specific phobias
no--> "minimal role" (largely due to lack of research) mainstay is CBT + exposures
53
name 4 antidepressants that have some (if small) evidence for benefit in treating specific phobias
paroxetine escitalopram fluoxetine (flying phobias) fluvoxamine (storm phobia)
54
is there evidence for adjunctive benzos combined with exposure therapy for specific phobias
no
55
what is the estimated lifetime prevalence of social anxiety disorder
8-12% internationally (higher rates in developed vs developing countries)
56
what is the mean age of onset of social anxiety disorder
12 years old
57
what is the typical course of social anxiety disorder
chronic and unremitting
58
list psychiatric conditions commoly comorbid with social anxiety disorder
MDD and other anxiety disorders = highest rates avoidant PD body dysmorphic disorder SUD ADHD schizophrenia
59
what are the main cognitive techniques involved in CBT for social anxiety disorder
restructuring and challenging maladaptive thoughts behavioural component --> typically in form of exposure therapy
60
how does efficacy compare between CBT and pharmacotherapy for social anxiety disorder
similar ?changes persist long with CBT
61
what type of CBT was found to be as effective as standard CBT but also improved relationship satisfaction and social approach behaviours
CBT focused in interpersonal behaviour
62
is there evidence to support IPT in social anxiety disorder
conflicting evidence likely more effective than wait list control but less effective than CBT
63
which has more long term benefit for treatment of social anxiety disorder, psychotherapy or pharmacotherapy
seems to be psychotherapy
64
list first line agents for treatment of social anxiety disorder + mnemonic
Every Fungus Packs Pretty Sweet Value Escitalopram Fluvoxamine and fluvoxamine CR Paroxetine and paroxetine CR Pregabalin Sertraline Venlafaxine XR l
65
list second line agents for social anxiety disorder + mnemonic
All Bros Can Carry Giant Pigs Alprazolam Bromazepam Citalopram Clonazepam Gabapentin Phenelzine
66
list two medications that are NOT recommended as adjunctive therapy for social anxiety disorder
clonazepam pindolol
67
are there any first line adjunctive therapies for social anxiety disorder
no--> only third line
68
list the (third line) adjunctive therapies for social anxiety disorder
abilify buspirone paroxetine risperidone
69
list medications NOT recommended in the treatment of social anxiety disorder
atenolol buspirone imipramine keppra propanolol quetiapine *beta blockers can be useful for performance but not generally
70
what doses of pregabalin have been shown to be effective for social anxiety disorder
higher doses (i.e 600mg/day) rather than lower doses (150mg/day) is effective *unclear how efficacy of pregabalin compares to SSRIs
71
how do benzos compare to SSRIs in efficacy for treating social anxiety disorder
similar efficacy but benzos are second line due to lack of action on other possible comobidities with social anxiety disorder + potential for abuse and dependence in those with history of SUDs
72
is quetiapine recommended for treatment of social anxiety disorder
no
73
is buspirone recommended for treatment of social anxiety disorder
no
74
is citalopram recommended for treatment of social anxiety disorder
second line
75
is gabapentin recommended for social anxiety disorder
second line
76
is phenelzine recommended for social anxiety disorder
second line
77
is there indication for long term medication treatment in social anxiety disorder
yes--> highly significant reduction in relapse rates with continued SSRI treatment compared to placebo over 3-6 months NNT = 3.57 (pregabalin also has evidence in reducing relapse rates)
78
is st johns wort recommended for treatment of social anxiety disorder
no failed to demonstrate superiority over placebo
79
has adding pharmacotherapy to CBT been shown to increase the benefits of CBT in the treatment of social anxiety disorder
no
80
what is the estimated lifetime prevalence of GAD
about 6%
81
what is the age of onset of GAD
may be bimodal median age is 31 years and mean age is 32.7 years
82
what is the usual age of onset for GAD in kids and teens
10-14 years
83
what % of those with GAD report painful physical symptoms
60-94% main reason for presentation in primary care in 72% of cases
84
what medical syndromes have elevated risk in those with GAD
pain syndromes HTN CV and gastro conditions
85
list problems that have been specifically identified among those with GAD that have become part of evidence based CBT protocols for GAD
intolerance of uncertainty poor problem solving confidence positive and negative metacognitive beliefs about the function or utility of worry
86
list psychotherapeutic interventions that have evidence in GAD treatment
Acceptance based behaviour therapy meta cognitive therapy CBT targeting intolerance of uncertainty adjunctive MBCT *meta analyses clearly support CBT
87
is psychodynamic therapy helpful for GAD
some studies--> short term psychodynamic is as effective as CBT for anxiety scores but CBT was better for worry and depression other studies--> no significant differences between brief psychodynamic, pharmacotherapy or combo
88
what are the benefits of adding pre treatment motivational interviewing as an adjunct to CBT for GAD
helps reduce resistance to therapy improves homework compliance improves worry outcomes
89
is psychotherapy, pharmacotherapy or combo best for treatment of GAD
meta analysis--> combo is better than CBT alone at post treatment but not as 6 month follow up (it was CBT + clonazepam or + buspirone vs CBT alone)
90
is there evidence to support the routine combo of CBT + pharmacotherapy in GAD
no--> but as in other anxiety disorders, when patients do not benefit from CBT or have limited response, trial of pharmacotherapy is advisable (and vice versa)
91
second line pharmacotherapy for GAD
Anyone Buying Biscuits Begins Quietly Hiding Desserts In Locked Vehicle Alprazolam Bromazepam Buproprion XL Buspirone Quetiapine Hydroxyzine Diazepam Imipramine Lorazepam Vortioxetine
92
name a second line adjunctive agent for treatment of GAD
pregabalin
93
name 4 third line adjunctive agents for treatment of GAD
aripiprazole olanzapine quetiapine/quetiapine XR risperidone
94
among the classes of meds in the second line agent group for GAD, which medications would generally be considered "first" among the second line agents
the benzodiazepines, except where there is a risk of substance use (buproprion would likely be reserved for later)
95
in which patients would you consider using quetiapine XR for treatment of GAD
patients who cannot be given antidepressants or benzos *does have good efficacy though, its just the concerns about metabolics due to being an AAP
96
how does efficacy compare between pregabalin and benzos in treatment of GAD
similar (pregabalin as effective as benzos) (and was more effective than venlafaxine in one trial and equally efficacious in another)
97
what is the evidence for use of vortioxetine in GAD
second line recommendation level 1, conflicting evidence one trial showed benefit one did not but ?due to difference in recruitment in the studies?
98
how does quetiapine compare in terms of efficacy to antidepressants for GAD
equally efficacious but lead to more weight gain and sedation and had higher dropout rates
99
what neurostimulation therapy may be beneficial for treatment of GAD
rTMS as monotherapy or adjunctive to SSRI
100
list 4 herbal preparations that may have efficacy in GAD
silexan (lavender oil) + galphemia glauca extract --> similar to lorazepam in efficacy passion flower--> as effective as benzos valerian *preparations are poorly standardized and thus difficult to recommend
101
name a lifestyle intervention that has evidence for improving GAD symptoms
weightlifting or aerobic exercise *significant symptomatic improvements compared to wait list condition
102
maternal anxiety disorders are associated with which 3 adverse pregnancy outcomes
elective c section premature delivery shorter gestational age *however, a meta analysis found no relationship between anxiety symptoms per se and adverse pregnancy outcomes
103
maternal anxiety and related disorders have been associated with what challenges/adverse outcomes with regard to parenting
mothers with anxiety and related disorders may be: -less promoting of psychological autonomy -associated with behavioural/emotional problems in kids -subsequent development of anxiety in the kid
104
what is the risk associated with prenatal benzo exposure
oral cleft increased risk (absolute risk is small... another case control study did not find this association) there is risk of neonatal withdrawal or toxicity syndrome *no increased risk found of major malformations or cardiac defects
105
what are the most common phobias reported in pediatric populations
blood/injury/injection and animal fears
106
anxiety and related disorders among younger patients are associated with high rates of what issues/disorders in addition
comorbid psych conditions SUD sleep problems somatic symptoms suicidality problems with cognition/attention problems with academic performance problems with peer relationships
107
is there a benefit to universal anxiety prevention programs for preventing childhood anxiety and related disorders? what about indicated prevention programs (targeted to children demonstrating highly anxious symptoms)?
both have evidence of benefit--> indicated programs have larger effect sizes than universal programs

Collège royal (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions